lactulose has been researched along with Liver Dysfunction in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (62.86) | 18.7374 |
1990's | 1 (2.86) | 18.2507 |
2000's | 9 (25.71) | 29.6817 |
2010's | 2 (5.71) | 24.3611 |
2020's | 1 (2.86) | 2.80 |
Authors | Studies |
---|---|
Bryce, K; Marelli, L; Ruban, A; Tern, PJW | 1 |
Khan, AA; Sarwar, S | 1 |
Owens, SL; Parnell, NK | 1 |
Halpin, LE; Yamamoto, BK | 1 |
Akkuş, MA; Bülbüller, N; Cetinkaya, Z; Doğru, O; Ilhan, YS; Kirkil, C; Ozercan, I | 1 |
Ueki, A | 1 |
Dhanjal, NS; Oatridge, A; Patel, N; Taylor-Robinson, SD; White, S | 1 |
McQuaid, TS | 1 |
Godai, K; Munemura, C; Murawaki, Y; Noguchi, K; Uemasu, J; Yamamoto, S | 1 |
Misra, P | 1 |
Batavier, P; de Groot, GH; Maas, HC; Schalm, SW; Schicht, I | 1 |
Tams, TR | 1 |
Brunner, G | 1 |
Heine, WD; Liehr, H | 1 |
Müting, D; Reikowski, J; Rosskopf, U | 1 |
Fields, JZ; Holmes, EW; Iber, F; Keshavarzian, A; Patel, M; Pethkar, S | 1 |
Takeuchi, H | 1 |
Kawata, S; Saito, T; Shinzawa, H; Togashi, H; Watanabe, H | 1 |
Holovach, IIu; Mytnyk, ZM; Neĭko, IeM | 1 |
Wienbeck, M | 1 |
Benzi-Cipelli, R; Bernardi, R; Magliulo, E; Scevola, D; Trpin, L | 1 |
Bossone, CM | 1 |
Pusch, JH; Ullmann, W | 1 |
Martini, GA | 1 |
Herrmann, R; Weber, FL | 1 |
Minuk, GY; Sarjeant, EJ | 1 |
Maier, KP | 1 |
Imai, F; Kameda, H | 1 |
Moroni, M | 1 |
Maddrey, WC | 1 |
Neumayr, A | 1 |
Kremer, H | 1 |
Seidlová, V | 1 |
Williams, R | 1 |
Breen, KJ; Hoyumpa, AM; Schenker, S | 1 |
7 review(s) available for lactulose and Liver Dysfunction
Article | Year |
---|---|
[Chronic liver disease].
Topics: Amino Acids, Branched-Chain; Chronic Disease; Diagnosis, Differential; Diet, Protein-Restricted; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Liver Diseases | 2003 |
[Chronic acquired(non-Wilsonian) hepatocerebral degeneration(CAHD)].
Topics: Amino Acids, Branched-Chain; Ammonia; Chronic Disease; Hepatolenticular Degeneration; Humans; Lactulose; Liver Diseases; Prognosis | 2000 |
[Long-term treatment of chronic hepatitis and liver cirrhosis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Chronic Disease; Diagnosis, Differential; Diet Therapy; Dietary Fats; Dietary Proteins; Diuretics; Hepatitis; Humans; Immunosuppressive Agents; Lactulose; Liver Cirrhosis; Liver Diseases; Long-Term Care; Penicillamine; Rest; Vitamin B 12 | 1975 |
Progress in the treatment of portal-systemic encephalopathy (PSE).
Topics: Amino Acids; Brain Diseases; Dietary Proteins; Humans; Intestinal Mucosa; Lactulose; Liver Diseases; Therapeutic Irrigation; Zinc | 1987 |
Branched chain amino acid therapy in liver disease.
Topics: Administration, Oral; Amino Acids; Amino Acids, Branched-Chain; Dietary Proteins; Glucose; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Diseases; Neomycin; Nitrogen; Nutrition Disorders; Parenteral Nutrition | 1985 |
[Advances in the treatment of liver disease].
Topics: Amino Acids; Anti-Bacterial Agents; Chronic Disease; Dihydroxyphenylalanine; Enzyme Induction; Exchange Transfusion, Whole Blood; gamma-Globulins; Hepatic Encephalopathy; Hepatitis; Hepatitis A; Humans; Immunosuppressive Agents; Lactulose; Liver Diseases; Peritoneal Dialysis | 1973 |
Hepatic encephalopathy: current status.
Topics: Adrenal Cortex Hormones; Amino Acids; Ammonia; Animals; Anti-Bacterial Agents; Biogenic Amines; Dihydroxyphenylalanine; Diuretics; Energy Metabolism; Exchange Transfusion, Whole Blood; Fatty Acids; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Intestines; Lactulose; Liver Diseases; Neurologic Manifestations; Oxygen Consumption; Portacaval Shunt, Surgical | 1974 |
2 trial(s) available for lactulose and Liver Dysfunction
Article | Year |
---|---|
Effects of melatonin and lactulose on the liver and kidneys in rats with obstructive jaundice.
Topics: Analysis of Variance; Animals; Cholestasis; Cholesterol; Kidney Diseases; Lactulose; Liver; Liver Diseases; Male; Malondialdehyde; Melatonin; Rats; Rats, Wistar | 2002 |
Changes in brain size in hepatic encephalopathy: a coregistered MRI study.
Topics: Aged; Brain; Brain Edema; Cohort Studies; Disease Progression; Female; Hepatic Encephalopathy; Humans; Lactulose; Lateral Ventricles; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Portasystemic Shunt, Surgical; Predictive Value of Tests; Reproducibility of Results; Treatment Outcome | 2004 |
26 other study(ies) available for lactulose and Liver Dysfunction
Article | Year |
---|---|
Hepatic encephalopathy: a rare cause of focal seizures in chronic liver disease.
Topics: Aftercare; Anticonvulsants; Chronic Disease; Diagnosis, Differential; Electroencephalography; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Diseases; Magnetic Resonance Imaging; Middle Aged; Rifaximin; Seizures; Treatment Outcome | 2020 |
Budd Chiari syndrome: a rare complication of renal cancer.
Topics: Albumins; Anti-Bacterial Agents; Ascites; Budd-Chiari Syndrome; Diuretics; Female; Gastrointestinal Agents; Hepatic Veins; Humans; Kidney Neoplasms; Lactulose; Liver Diseases; Middle Aged; Thromboembolism; Vena Cava, Inferior | 2008 |
What is the evidence? Portosystemic shunt in a dog.
Topics: Animals; Anti-Ulcer Agents; Diet; Dog Diseases; Dogs; Evidence-Based Medicine; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Lactulose; Liver Diseases; Male; Omeprazole; Portal System; Stomach Ulcer; Treatment Outcome | 2011 |
Peripheral ammonia as a mediator of methamphetamine neurotoxicity.
Topics: Alanine Transaminase; Ammonia; Analysis of Variance; Animals; Aspartate Aminotransferases; Benzodiazepines; Biogenic Monoamines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Fever; Gene Expression Regulation; Lactulose; Liver Diseases; Male; Mass Spectrometry; Methamphetamine; Microdialysis; Neuroprotective Agents; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Time Factors | 2012 |
Medical management of a patent ductus venosus in a dog.
Topics: Animals; Anti-Bacterial Agents; Diagnosis, Differential; Diet, Protein-Restricted; Dog Diseases; Dogs; Gastrointestinal Agents; Lactulose; Liver Diseases; Male; Portal System; Treatment Outcome; Vena Cava, Inferior | 2005 |
[Case of autosomal dominant polycystic kidney disease presenting hepatic encephalopathy].
Topics: Aged; Cysts; Female; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Diseases; Polycystic Kidney, Autosomal Dominant; Renal Dialysis; Renal Veins; Splenic Vein | 2005 |
Hepatic encephalopathy.
Topics: Amino Acids; Ammonia; Bromocriptine; Constipation; Dietary Proteins; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Infections; Kidney Diseases; Lactulose; Levodopa; Liver Diseases; Neomycin; Neurotransmitter Agents | 1981 |
Incidence of endotoxemia in pigs with ischemic hepatic necrosis treated by hemodialysis. Prevention of endotoxemia with lactulose.
Topics: Animals; Disaccharides; Disease Models, Animal; Endotoxins; Enema; Ischemia; Lactulose; Liver; Liver Diseases; Necrosis; Renal Dialysis; Sepsis; Swine | 1983 |
Management of liver disease in dogs and cats.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Bacterial Infections; Cat Diseases; Cats; Cimetidine; Diuretics; Dog Diseases; Dogs; Lactulose; Liver Diseases; Prednisolone | 1984 |
[Acute liver failure--therapeutic aspects 1982].
Topics: Acute Disease; Animals; Antithrombins; Blood Coagulation Factors; Cimetidine; Dietary Carbohydrates; Enema; Exchange Transfusion, Whole Blood; Gastrointestinal Hemorrhage; Glucose; Humans; Lactulose; Liver Diseases; Neomycin; Papio; Paromomycin; Peptic Ulcer; Plasma Exchange | 1982 |
Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously.
Topics: Animals; Chemical and Drug Induced Liver Injury; Disaccharides; Endotoxins; Galactosamine; Infusions, Parenteral; Lactulose; Liver; Liver Diseases; Rats | 1981 |
[Bifidum-milk and lactulose in the therapy of chronic liver diseases].
Topics: Ammonia; Child; Disaccharides; Female; Humans; Lactobacillus; Lactulose; Liver Cirrhosis; Liver Diseases; Phenols | 1980 |
Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage.
Topics: Aged; Alcoholism; Chronic Disease; Digestive System; Humans; Intestinal Absorption; Lactulose; Liver Cirrhosis, Alcoholic; Liver Diseases; Male; Mannitol; Middle Aged; Permeability; Sucrose | 1999 |
Home lactulose enema: prevention of hepatic encephalopathy at home.
Topics: Enema; Gastrointestinal Agents; Hepatic Encephalopathy; Home Nursing; Humans; Lactulose; Liver Diseases; Male; Middle Aged; Patient Readmission; Self Administration | 2002 |
[Different therapeutic approaches for chronic diffuse liver lesions using ornicetil, lactulose, etimizol and corinfar].
Topics: Etimizol; Hepatic Encephalopathy; Hepatitis, Chronic; Humans; Lactulose; Liver Cirrhosis; Liver Diseases; Middle Aged; Nifedipine; Ornithine; Treatment Outcome | 2002 |
[The treatment of hepatic emergencies].
Topics: Cimetidine; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Diseases; Male; Parenteral Nutrition; Poisoning; Pregnancy; Pregnancy Complications; Water-Electrolyte Balance | 1979 |
Control of endotoxinemia in liver disease by lactulose and paromomycin.
Topics: Chronic Disease; Disaccharides; Endotoxins; Hepatitis; Hepatitis B; Humans; Lactulose; Limulus Test; Liver Cirrhosis; Liver Diseases; Paromomycin | 1979 |
The liver: a pharmacologic perspective.
Topics: Acetaldehyde; Alcoholism; Chemical and Drug Induced Liver Injury; Diuretics; Drug-Related Side Effects and Adverse Reactions; Ethanol; Hepatic Encephalopathy; Humans; Inactivation, Metabolic; Lactulose; Levodopa; Liver; Liver Cirrhosis; Liver Diseases; Microsomes, Liver; Neomycin; Oxidation-Reduction; Pharmaceutical Preparations; Spironolactone; Vasopressins | 1977 |
[Psychiatric-neurological disorders in chronic liver diseases].
Topics: Acute Disease; Ammonia; Biotransformation; Brain Damage, Chronic; Brain Diseases; Chronic Disease; Dietary Proteins; Diuretics; Glutamine; Humans; Lactulose; Liver Diseases; Mental Disorders; Portacaval Shunt, Surgical; Postoperative Complications; Prognosis | 1975 |
Lactulose and ammonia.
Topics: Ammonia; Disaccharides; Humans; Lactulose; Liver Diseases; Pectins | 1987 |
The effect of (a) neomycin and lactulose treatment on systemic and portal serum GABA levels in rats and (b) pH changes on [3H] GABA binding to isolated rat hepatocytes.
Topics: Animals; Common Bile Duct; Disaccharides; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Homeostasis; Hydrogen-Ion Concentration; Lactulose; Ligation; Liver; Liver Diseases; Male; Neomycin; Portal Vein; Rats; Rats, Inbred Strains | 1988 |
[Liver diseases and colonic dysfunction].
Topics: Colon; Colonic Diseases; Female; Humans; Lactulose; Liver Circulation; Liver Diseases; Middle Aged; Regional Blood Flow; Vancomycin | 1988 |
[Treatment of constipation with lactulose in acute and chronic hepatopathy].
Topics: Constipation; Disaccharides; Humans; Lactulose; Liver; Liver Diseases; Urea | 1986 |
[Intestine and liver-protective therapy].
Topics: Diabetes Mellitus; Disaccharides; Dyspepsia; Gastrointestinal Motility; Humans; Lactobacillus; Lactulose; Liver Cirrhosis; Liver Diseases | 1974 |
[Lactulose in the treatment of chronic portosystemic encephalopathies].
Topics: Adult; Aged; Chronic Disease; Disaccharides; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Diseases; Male; Mental Disorders; Middle Aged; Nervous System Diseases | 1974 |
Hepatic encephalopathy.
Topics: Acetaminophen; Ammonia; Animals; Brain; Brain Edema; Diet Therapy; Dopamine; Female; Humans; Lactulose; Liver Diseases; Liver Transplantation; Male; Neomycin; Nervous System Diseases; Parabiosis; Renal Dialysis; Serotonin; Suicide; Swine; Tryptophan | 1973 |